Current Status of Therapeutic Approaches and Vaccines for SARS-CoV-2 | Zendy

Braira Wahid | Zendy; Anam Amir | Zendy; Ayesha Ameen | Zendy; Muhammad Idrees | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current Status of Therapeutic Approaches and Vaccines for SARS-CoV-2

Author(s) -

Braira Wahid,

Anam Amir,

Ayesha Ameen,

Muhammad Idrees

Publication year - 2021

Publication title -

future microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.797

H-Index - 82

eISSN - 1746-0921

pISSN - 1746-0913

DOI - 10.2217/fmb-2020-0147

Subject(s) - medicine , pandemic , intensive care medicine , clinical trial , covid-19 , bioburden , global health , virology , public health , disease , infectious disease (medical specialty) , outbreak , pathology , surgery

SARS-CoV-2, declared a pandemic in March 2020, is the current global health challenge. The global bioburden of this virus is increasing at a rapid pace. Many antiviral drugs and vaccines have been registered for clinical trials because of their inhibitory activity observed in vitro . Currently, five types of vaccines have successfully passed Phase IV clinical trial and are being administered in populations worldwide. A plethora of experimental designs have been proposed worldwide in order to find a safe and efficacious treatment option. Therefore, it is necessary to provide baseline data and information to clinicians and researchers so that they can review the current status of therapeutics and efficacy of already developed vaccines. This review article summarizes all therapeutic options that may help to combat SARS-CoV-2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research